ALN-XDH

N/A

Report date: 2023/03/24 20:00:46
NME

Base Information

Drug NameALN-XDH
Drug Alias NameALN XDH
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionXanthine dehydrogenase inhibitorsRNA interference
TargetsXanthine dehydrogenase
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlnylam Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGout

Other Information

ATC CodeN/A
Related LinksN/A